Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,955 | -3,858 | -2,003 | -613 | -1,752 |
| Depreciation Amortization | 5,982 | 4,626 | 2,555 | 1,207 | 3,602 |
| Income taxes - deferred | 305 | 221 | 129 | 126 | 190 |
| Accounts receivable | -4,437 | -5,831 | -2,432 | -1,606 | -2,986 |
| Accounts payable and accrued liabilities | 3,054 | 3,189 | 1,595 | 815 | 172 |
| Other Working Capital | -733 | -1,910 | -908 | -977 | -1,659 |
| Other Operating Activity | 8,931 | 8,874 | 4,642 | 2,177 | 5,833 |
| Operating Cash Flow | $10,147 | $5,311 | $3,578 | $1,129 | $3,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -853 | -482 | -351 | -86 | -367 |
| Net Acquisitions | -22,194 | -8,166 | -8,166 | -8,166 | N/A |
| Investing Cash Flow | $-23,047 | $-8,648 | $-8,517 | $-8,252 | $-367 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 20,000 | 20,000 | 5,500 |
| Debt Repayment | -38,018 | -37,715 | -12,072 | -11,949 | -9,514 |
| Common Stock Issued | 68,582 | 67,830 | 249 | 205 | 300 |
| Other Financing Activity | -170 | -170 | -170 | -170 | 431 |
| Financing Cash Flow | $50,394 | $49,945 | $8,007 | $8,086 | $-3,283 |
| Beginning Cash Position | 5,913 | 5,913 | 5,913 | 5,913 | 6,163 |
| End Cash Position | 43,407 | 52,521 | 8,981 | 6,876 | 5,913 |
| Net Cash Flow | $37,494 | $46,608 | $3,068 | $963 | $-250 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,147 | 5,311 | 3,578 | 1,129 | 3,400 |
| Capital Expenditure | -853 | -482 | -351 | -86 | -367 |
| Free Cash Flow | 9,294 | 4,829 | 3,227 | 1,043 | 3,033 |